ACC 2018 Conference
ACC 2018 Conference
Advertisement
DocWire News EditorsACC 2018 Conference | April 17, 2025
A “triple pill” combination therapy consisting of three different blood pressure medications reduced blood pressure ...
Read More
DocWire News EditorsACC 2018 Conference | April 17, 2025
An analysis of a subset of patients from the CANTOS trial suggested that canakinumab does not prevent prediabetes from ...
DocWire News EditorsACC 2018 Conference | April 17, 2025
A month-long treatment regimen with a novel inhaled inorganic nitrate yielded no significant improvement in exercise ...
DocWire News EditorsACC 2018 Conference | April 17, 2025
The beta-blocker carvedilol showed some benefit for protecting against heart injury resulting from chemotherapy-induced ...
DocWire News EditorsACC 2018 Conference | April 17, 2025
Patients younger than 75 years of age who suffered an MI and were given ticagrelor did not see an increased risk for ...
DocWire News EditorsACC 2018 Conference | April 17, 2025
In patients who recently suffered an acute coronary syndrome (ACS), the PCSK9 inhibitor alirocumab was associated with a ...
Advertisement
Advertisement